Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Unapproved antibiotic usage on rise in India; Azithromycin, cefixime most used tablets, finds study

A research study published in The Lancet has talked about one of the most serious habits of Indians which should have been talked about earlier. The study says close to 50% of the antibiotic formulations used in India's private sector in 2019 were not approved by the central drug regulator.

The Times of India

Tissue Regenix narrows losses but lingering impact of Covid weighs on healthcare market

The Leeds-based creator of regenerative medical devices increased revenues across the first half of 2022

Birmingham Post

Fear-mongering about fentanyl for kids

One expert characterized the DEA's claims as propaganda that was "divorced from reality"

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees

Cathie Wood’s ARK Genomic Revolution EFT has been making big investments in the psychedelics sector since February 2022, most notably in A

Benzinga

Talented cricketer was supplying 'laughing gas' to Nottingham students

Canisters of the drug were found in a car

Nottingham Post

Argentina hikes biofuel prices for domestic market

Argentina's government on Tuesday increased domestic prices of biodiesel for blending with diesel, as well as for bioethanol made from sugarcane and corn.

Reuters

Tetra Partners With Cellvera To Develop An Oral Treatment For COVID-19

Tetra Bio-Pharma Inc.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

When will Omicron boosters be available? Who is eligible for Covid jab and how to book

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme

Daily Mirror

What is rotavirus and why is it in the news?

Everything you need to know about rotavirus

Evening Standard

The abortion rights movement can learn from the Aids activism of the 80s and 90s

Act Up employed a multiplicity of tactics and responses while maintaining a laser-focused singleness of purpose

The Guardian - US

Application for Omicron vaccine expected in 'the coming months'

It could take several months for Pfizer's new Omicron-specific vaccines to be available in New Zealand.

Newsroom.co.nz

CanSino's inhaled Covid-19 vaccine gets emergency use approval in China

HONG KONG: China's CanSino Biologics Inc said on Sunday that its recently developed Covid-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.

Bangkok Post

CanSino's inhaled COVID-19 vaccine gets emergency use approval in China

China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business.

Reuters

Second Covid booster jab approved in UK ahead of winter vaccine programme

It’s the second jab aimed at both the original and Omicron strains of the virus, to be approved in the UK

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

New 'second generation' Pfizer Covid vaccine approved ahead of booster programme

The "bivalent" jab - which targets Omicron as well as the original strain of the deadly virus - is manufactured by Pfizer/Biotech, and follows a similar booster from Moderna approved last month

Manchester Evening News

A new vaccine which protects against two strains of covid has been approved for the NHS to use this autumn

It targets both the original strain of coronavirus and the Omicron variant

The Independent UK

Pfizer/BioNTech Covid-19 booster approved by UK medicines regulator

The vaccine targets both the original strain of coronavirus and the Omicron variant.

The Guardian - AU

US-level mortality? Sounding the alarm about fentanyl overdose in Australia

Deaths from the powerful opioid, along with pethidine and tramadol, are up a staggering 1,275% since 2006. A new report warns without ‘decisive action’ a crisis looms

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Pfizer criticised by conservatives for excluding white and Asian applicants from scholarship programme

Company says scheme will boost minority representation

The Independent UK

FDA still skeptical of ALS drug ahead of high-stakes meeting

The U.S. Food and Drug Administration has posted another negative review of a closely watched drug for the deadly neurodegenerative disease ALS

Al Jazeera

‘Completely new’ COVID strains possible in winter: EU drug agency

Existing vaccines and adaptive ones should protect people from serious illness and death, the EU agency says.

Benzinga

Is Cannabis Legalization The End For Pharma Stocks? New Study Predicts Billions In Losses

Federal cannabis legalization might reduce conventional pharmaceutical sales by billions of dollars according to a new study cond

Radio France Internationale

EU regulator gives green light to omicron booster vaccines

The European Medicines Agency (EMA) has backed two separate Covid-19 booster vaccines updated to target the omicron variant of Covid-19 and developed by drugmakers Moderna and BioNTech-Pfizer.

The Denver Post

New omicron COVID-19 boosters are coming. Here’s what you need to know

DENVER — COVID-19 booster shots with a new omicron-targeting recipe are expected to arrive in pharmacies and clinics next week, but the experience of getting them will be largely the same as previous rounds of the vaccine.

Axios

"Game-changer" Paxlovid turns into pandemic enigma

Paxlovid goes from COVID game-changer to pandemic enigma

1 … 129 130 131 132

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

European Medicines Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.